Skip to content

Profound Medical Corp.

PROF

CIK 0001628808

← back to feed
Revenue (TTM)
$11.92M
+65.1% YoY Q1 May 2026
Net Income (TTM)
−$41.45M
−53.0% YoY Q1 May 2026
EPS Diluted (TTM)
$1.33
+25.9% YoY Q1 May 2026
Gross Margin
94.2%
Q1 May 2026
Operating Margin
-351.5%
Q1 May 2026
Net Margin
-347.6%
Q1 May 2026
Free Cash Flow (TTM)
−$38.38M
Q1 May 2026
Cash
$50.3M
Q1 May 2026
Total Debt
$9M
Q1 May 2026
Shares Outstanding
36.34M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings